SHBG, sex hormones, and inflammatory markers in older women.
暂无分享,去创建一个
S. Bandinelli | L. Ferrucci | A. Corsi | J. Guralnik | F. Giallauria | E. Dall’aglio | G. Zuliani | F. Lauretani | G. Ceresini | M. Maggio | Stefano Parrino | S. Basaria | G. Ceda | C. Cattabiani | F. Ablondi
[1] W. Mbagaya. Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease , 2010 .
[2] S. Bandinelli,et al. Anabolic and catabolic biomarkers as predictors of muscle strength decline: the InCHIANTI study. , 2010, Rejuvenation research.
[3] Y. Schouw,et al. Testosterone, SHBG and cardiovascular health in postmenopausal women , 2010, International Journal of Impotence Research.
[4] M. Jarvelin,et al. Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes , 2009, Human molecular genetics.
[5] S. Bandinelli,et al. Relationship Between Higher Estradiol Levels and 9‐Year Mortality in Older Women: The Invecchiare in Chianti Study , 2009, Journal of the American Geriatrics Society.
[6] M. Szklo,et al. Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis. , 2009, Atherosclerosis.
[7] S. Bandinelli,et al. Elevated C-reactive protein levels and metabolic syndrome in the elderly: The role of central obesity data from the InChianti study. , 2009, Atherosclerosis.
[8] L. Shaw,et al. Relations between endogenous androgens and estrogens in postmenopausal women with suspected ischemic heart disease. , 2008, The Journal of clinical endocrinology and metabolism.
[9] D. Grobbee,et al. Endogenous sex hormones and C‐reactive protein in healthy postmenopausal women , 2008, Journal of internal medicine.
[10] P. Spritzer,et al. Relationship between endogenous testosterone and cardiovascular risk in early postmenopausal women. , 2008, Metabolism: clinical and experimental.
[11] S. Bandinelli,et al. Sex hormone binding globulin levels across the adult lifespan in women — The role of body mass index and fasting insulin , 2008, Journal of endocrinological investigation.
[12] G. Can,et al. Serum sex hormone-binding globulin, a determinant of cardiometabolic disorders independent of abdominal obesity and insulin resistance in elderly men and women. , 2007, Metabolism: clinical and experimental.
[13] D. McKenzie,et al. Endogenous androgen levels and cardiovascular risk profile in women across the adult life span , 2007, Menopause.
[14] S. Bandinelli,et al. Association of hormonal dysregulation with metabolic syndrome in older women: data from the InCHIANTI study. , 2007, American journal of physiology. Endocrinology and metabolism.
[15] F. Orio,et al. Cardiovascular risk in women with polycystic ovary syndrome. , 2006, Fertility and sterility.
[16] L. Ferrucci,et al. Interleukin-6 in aging and chronic disease: a magnificent pathway. , 2006, The journals of gerontology. Series A, Biological sciences and medical sciences.
[17] E. Ding,et al. Sex differences of endogenous sex hormones and risk of type 2 diabetes: a systematic review and meta-analysis. , 2006, JAMA.
[18] J. Manson,et al. Sex hormone-binding globulin and serum testosterone are inversely associated with C-reactive protein levels in postmenopausal women at high risk for cardiovascular disease. , 2006, Annals of epidemiology.
[19] E. Barrett-Connor,et al. Cross-sectional association between markers of inflammation and serum sex steroid levels in the postmenopausal estrogen/progestin interventions trial. , 2006, Journal of women's health.
[20] S. Bandinelli,et al. Correlation between testosterone and the inflammatory marker soluble interleukin-6 receptor in older men. , 2006, The Journal of clinical endocrinology and metabolism.
[21] A. Folsom,et al. Association of Endogenous Hormones with C-reactive Protein, Fibrinogen, and White Blood Count in Post-menopausal Women , 2005, European Journal of Epidemiology.
[22] S. Bandinelli,et al. CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS The , 2004 .
[23] M. Szklo,et al. Endogenous postmenopausal hormones and serum lipids: the atherosclerosis risk in communities study. , 2005, The Journal of clinical endocrinology and metabolism.
[24] J. Manson,et al. Sex Hormone Levels and Risk of Cardiovascular Events in Postmenopausal Women , 2003, Circulation.
[25] S. Kahn,et al. BEYOND CARRIER PROTEINS Sex hormone-binding globulin is synthesized in target cells , 2002 .
[26] C. Heinlein,et al. The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions. , 2002, Molecular endocrinology.
[27] E. Milgrom,et al. The postmenopausal ovary is not a major androgen-producing gland. , 2001, The Journal of clinical endocrinology and metabolism.
[28] M. Szklo,et al. Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation. , 2001, American journal of epidemiology.
[29] C. Longcope. Endocrine Function of the Postmenopausal Ovary , 2001, Journal of the Society for Gynecologic Investigation.
[30] Luigi Ferrucci,et al. Subsystems Contributing to the Decline in Ability to Walk: Bridging the Gap Between Epidemiology and Geriatric Practice in the InCHIANTI Study , 2000, Journal of the American Geriatrics Society.
[31] C. Mendelson,et al. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4. , 1996, Molecular endocrinology.
[32] J. Morley,et al. Endocrinology in aging. , 1988, Disease-a-month : DM.